[1] AMUNDSON S A. Transcriptomics for radiation biodosimetry:progress and challenges[J]. Int J Radiat Biol, 2023, 99(6):925-933. [2] GNANASEKARAN T S. Cytogenetic biological dosimetry assays:recent developments and updates[J]. Radiat Oncol J,2021, 39(3):159-166. [3] BLAKELY W F, MADRID J P, SANDGREN D J. Biodosimetry medical recording-use of the biodosimetry assessment tool[J].Health Phys, 2010, 99(Suppl 5):S184-S191. [4] CHIN C H, CHEN S H, WU H H, et al. cytoHubba:identifying hub objects and sub-networks from complex interactome[J].BMC Syst Biol, 2014, 8(Suppl 4):S11. [5] JACOBS A R, GUYON T, HEADLEY V, et al. Role of a high throughput biodosimetry test in treatment prioritization after a nuclear incident[J]. Int J Radiat Biol, 2020, 96(1):57-66. [6] LEE Y, PUJOL CANADELL M, SHURYAK I, et al. Candidate protein markers for radiation biodosimetry in the hematopoietically humanized mouse model[J]. Sci Rep, 2018, 8(1):13557. [7] PANNKUK E L, LAIAKIS E C, AUTHIER S, et al. Targeted metabolomics of nonhuman primate serum after exposure to ionizing radiation:potential tools for high-throughput biodosimetry[J]. RSC Adv, 2016, 6(56):51192-51202. [8] HE N N, SUN Y X, YANG M M, et al. Analysis of circular RNA expression profile in HEK 293T cells exposed to ionizing radiation[J]. Dose Response, 2019, 17(2):1559325819837795. [9] WANG C, LIU H. Factors influencing degradation kinetics of mRNAs and half-lives of microRNAs, circRNAs, lncRNAs in blood in vitro using quantitative PCR[J]. Sci Rep, 2022, 12(1):7259. [10] 何颖,沈先荣,钱甜甜,等.低剂量γ-射线照射人淋巴母细胞诱导BTG2基因mRNA变化[J].辐射研究与辐射工艺学报,2015, 33(1):20-24. [11] XU D, WANG Y, WANG J, et al. The potential regulatory roles of lncRNAs in DNA damage response in human lymphocytes exposed to UVC irradiation[J]. Biomed Res Int, 2020, 2020:8962635. [12] CRUZ-GARCIA L, O’BRIEN G, SIPOS B, et al. Generation of a transcriptional radiation exposure signature in human blood using long-read nanopore sequencing[J]. Radiat Res, 2020, 193(2):143-154. [13] MANNING G, TICHÝA, SIRÁK I, et al. Radiotherapyassociated long-term modification of expression of the inflammatory biomarker genes ARG1 BCL2L1 and MYC[J].Front Immunol, 2017, 8:412. [14] SALAH A, WOLLSCHLÄGER D, CALLARI M, et al. Genomewide transcriptomic response of whole blood to radiation[J]. Sci Rep, 2025, 15(1):19840. [15] NAJAFI M, SHIRAZI A, MOTEVASELI E, et al. The melatonin immunomodulatory actions in radiotherapy[J].Biophys Rev, 2017, 9(2):139-148. [16] YU H, PARDOLL D, JOVE R. STATs in cancer inflammation and immunity:a leading role for STAT3[J]. Nat Rev Cancer,2009, 9(11):798-809. [17] ZENG X L, LUO D Q, ZHANG S, et al. High-dose radiation-induced immunogenic cell death of bladder cancer cells leads to dendritic cell activation[J]. PLoS One, 2024, 19(9):e0307024. [18] ADAWI A, ZHANG Y, BAGGS R, et al. Blockade of CD40-CD40 ligand interactions protects against radiationinduced pulmonary inflammation and fibrosis[J]. Clin Immunol Immunopathol, 1998, 89(3):222-230. [19] LAU M Y H, ISLAM KHAN M Z, LAW H K W. Molecular mechanism of radioresponsiveness in colorectal cancer:a systematic review[J]. Genes, 2024, 15(10):1257. [20] MORENO-VILLANUEVA M, ZHANG Y, FEIVESON A, et al.Single-cell RNA-sequencing identifies activation of TP53 and STAT1 pathways in human T lymphocyte subpopulations in response to ex vivo radiation exposure[J]. Int J Mol Sci, 2019, 20(9):2316. [21] ABEND M, BLAKELY W F, OSTHEIM P, et al. Early molecular markers for retrospective biodosimetry and prediction of acute health effects[J]. J Radiol Prot, 2022, 42(1).DOI:10.1088/1361-6498/ac2434. [22] OKAZAKI R. Role of p53 in regulating radiation responses[J].Life, 2022, 12(7):1099. |